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All RNA viruses encode an RNA-dependent RNA polymerase (RdRp), which in arteriviruses is expressed
as the C-terminal domain of nonstructural protein 9 (nsp9). Previously, potent primer-dependent RdRp
activity has been demonstrated for the homologous polymerase subunit (nsp12) of the distantly related
coronaviruses. The only previous study focusing on the in vitro activity of nsp9 of an arterivirus (equine
arteritis virus; EAV) reported weak de novo polymerase activity on homopolymeric RNA templates.
However, this activity was not retained when Mn2þ ions were omitted from the assay or when biolo-
gically relevant templates were supplied, which prompted us to revisit the biochemical properties of this
polymerase. Based on the properties of active-site mutants, we conclude that the RNA-synthesizing
activities observed in de novo and primer-dependent polymerase and terminal transferase assays cannot
be attributed to recombinant EAV nsp9-RdRp. Our results illustrate the potential pitfalls of characterizing
polymerases using highly sensitive biochemical assays.
& 2015 Elsevier Inc. All rights reserved.Introduction
Polymerases, enzymes that catalyze the templated synthesis of
polynucleotides in the 50–30 direction, are encoded by all organ-
isms and RNA viruses, as well as some DNA viruses. Reﬂecting the
principal differentiation into DNA- and RNA-based processes and
functions, they can be grouped into four classes, each possessing a
distinct combination of speciﬁcities for their substrate (NTPs or
dNTPs) and template (RNA or DNA) under physiological condi-
tions. Despite these fundamental differences in terms of substrate
requirements, many polymerases in these four classes, including
all characterized RNA-dependent RNA polymerases (RdRps),
employ the same catalytic mechanism and a similar three-
dimensional fold, which resembles the shape of a right hand
with ﬁnger, thumb, and palm domains (Iyer et al., 2003; Ng et al.,
2008). At the sequence level, these polymerases share motifs A
and C, which reside in the most conserved palm domain (Delarue
et al., 1990). A few conserved residues, primarily aspartates, loca-
ted in these motifs are involved in (d)NTP binding and/or catalysis
(Arnold et al., 2005; Arnold and Cameron, 2004) and consequently
their replacement should abolish or at least severely decrease
nucleic acid synthesis (Ng et al., 2008).Microbiology, Leiden
C Leiden, The Netherlands.
uma).Based on their requirements for initiation of nucleic acid synth-
esis, two types of polymerases are recognized: primer-dependent
and de novo-initiating enzymes (Ng et al., 2008; van Dijk et al., 2004).
The latter, to our knowledge exclusively (DNA- or RNA-dependent)
RNA polymerases, are capable of positioning the ﬁrst two NTPs,
typically two purines, in a manner that allows the formation of a
starting dinucleotide. In contrast, primer-dependent polymerases
are unable to accommodate the stable association between the ﬁrst
(d)NTP and the template that is required for de novo initiation.
Consequently, the formation of a ﬁrst dinucleotide is an energetically
extremely unfavorable event and to overcome this problem short
RNA primers must be recruited, placed on the template, and
extended. For this purpose, organisms and viruses have evolved
different priming mechanisms that are all supported by additional
proteins or domains. They may involve the synthesis of short RNA
fragments (by e.g. eukaryotic DNA primase (Pellegrini, 2012)), the
formation of covalent RNA-protein complexes (e.g. picornavirus VPg-
RNA complexes (Steil and Barton, 2009)), or the utilization of
tRNAs (by lentivirus tRNA-binding domains (Kleiman, 2002)) or cap-
bearing 50 fragments cleaved from cellular mRNAs (generated by
inﬂuenza virus, bunyavirus, and arenavirus endoribonuclease and
cap-binding domains (Boivin et al., 2010; Morin et al., 2010; Reguera
et al., 2010)).
In viruses of the order Nidovirales (comprising the families
Arteriviridae, Coronaviridae, Mesoniviridae, and Roniviridae), which
are characterized by their large to exceptionally large single-
stranded RNA genomes (de Groot et al., 2012; Lauber et al.,
K.C. Lehmann et al. / Virology 487 (2016) 68–74 692012), a canonical RdRp is expressed from ORF1b as part of the
pp1ab replicase polyprotein. After proteolytic cleavage, a protein
subunit (nonstructural protein 9 (nsp9) in Arteriviridae, nsp12 in
Coronaviridae) harboring conserved RdRp motifs in its C-terminal
two-thirds is released (Gorbalenya et al., 1989; Lauber et al., 2012;
Lehmann et al., 2015; van Dinten et al., 1996; Ziebuhr and Siddell,
1999). This cleavage product is a key subunit of the membrane-
associated multi-subunit enzyme complex that mediates the
synthesis of diverse viral RNAs (Sawicki et al., 2007; van Hemert et
al., 2008a; van Hemert et al., 2008b). This complex has been
characterized in situ and through reconstitution of its activities
in vitro. In one of these studies severe acute respiratory syndrome
coronavirus (SARS-CoV) was proposed to express a second, non-
canonical RNA polymerase subunit: the ORF1a-encoded nsp8
(Imbert et al., 2006), which was described as an obligatory de
novo-initiating polymerase capable of synthesizing products of
less than six nucleotides (Imbert et al., 2006). Since nsp12 was
found to be primer-dependent (te Velthuis et al., 2010a), it was
speculated that the two proteins may work sequentially on the
same template, with nsp8 providing the primers required by the
nsp12 “main RdRp”. Although supported by some biochemical
studies on nsp8 of other coronaviruses (Xiao et al., 2012), other
results called into question this clear division of labor between
nsp8 and nsp12 (te Velthuis et al., 2012; Ahn et al., 2012). Most
recently, the addition of nsp7 and nsp8 was shown to activate the
primer extension activity of SARS-CoV nsp12 in an in vitro assay
(Subissi et al., 2014). The same protein combination was required
for de novo initiation of RNA synthesis. The nsp7-nsp8 complex by
itself, on the other hand, did not show any polymerase activity and
was therefore proposed to serve as an activator and processivity
factor for the nsp12 RdRp.
Besides SARS-CoV nsp12, RdRp activity was studied previously
for only one other nidovirus “main RdRp”, nsp9 of the arterivirus
equine arteritis virus (EAV; Beerens et al., 2007). In that study,
weak de novo RdRp activity was reported on poly-uridine (pU) and
poly-cytidine (pC) single-stranded RNAs, while no primer exten-
sion or terminal transferase activity, i.e. the non-templated elon-
gation of RNA strands, was detected. Thus, it was concluded that
EAV nsp9 activity is restricted to de novo initiation. However, the
relevance of the observed activity for virus replication remained
uncertain since activity on templates containing appropriate virus-
speciﬁc sequences could not be detected and the in vitro activity
required the presence of Mn2þ , which is known to relieve tem-
plate requirements for other polymerases (Arnold et al., 1999). One
possible explanation for the lack of initiation on virus-speciﬁc
templates could be that additional co-factors, e.g. higher-order
RNA structures or proteins, are needed for genuine de novo
initiation in vivo. Therefore the aim of this study was to char-
acterize the RNA polymerase activity of EAV nsp9 in more detail.
We report the results of a carefully controlled study involving
several preparations of puriﬁed recombinant EAV nsp9, including
the wild-type protein and a set of active-site mutants, which were
tested for de novo and primer-dependent polymerase and terminal
transferase activities. However, the RdRp domain of recombinant
EAV nsp9 did not speciﬁcally display any of these activities and we
were thus unable to reproduce the published polymerase activity
of the protein. Furthermore, we noticed a striking resemblance
between the product proﬁle of one of the tested nsp9 preparations
and that of T7 phage RNA polymerase. Our results emphasize the
need to employ diverse controls when utilizing highly sensitive
biochemical assays.Results and discussion
Expression and puriﬁcation of EAV nsp9 using two vectors
Previously, the puriﬁcation and de novo polymerase activity of
recombinant EAV nsp9 were described (Beerens et al., 2007). In that
study the viral protein (which will be referred to as nsp9/pDEST) was
expressed from a pDEST vector with a C-terminal hexahistidine tag in
E. coli BL21 (DE3). Typically, an unknown fraction of such bacterially
expressed proteins may contain an N-terminal formylmethionine,
due to saturation of the endogenous protein processing pathway by
nsp9 overexpression. Such an N-terminal extension would not be
consistent with the authentic N-terminus of nsp9, which is expected
to be a glycine residue derived from the proteolytic release of nsp9
from the pp1ab polyprotein by nsp4-mediated cleavage of the
Glu1677↓Gly1678 site (Snijder et al., 1996). As it was previously
reported for SARS-CoV nsp8 and nsp12 that such foreign N-terminal
sequences may inﬂuence RdRp activity and stability, respectively (te
Velthuis et al., 2010a, 2012), we decided to also express EAV nsp9 as
part of a ubiquitin fusion protein by using a pASK vector (Gohara et
al., 1999; te Velthuis et al., 2010a) yielding a product that will here-
after be referred to as nsp9/pASK. Co-expression of the ubiquitin-
speciﬁc protease UBP1, which can remove the N-terminal ubiquitin
fusion partner in bacterio, enabled us to reproduce the natural glycine
N-terminus of nsp9. An additional advantage of the pASK vector is
that it allows expression to be driven by the endogenous pool of E.
coli RNA polymerase after induction with anhydrotetracycline. In
contrast, nsp9/pDEST was expressed from a T7 promoter. The
potential presence of the phage T7 RNA polymerase in the ultimate
nsp9 preparations, with previously demonstrated weak RdRp activity
(Beerens et al., 2007), could be of concern.
Both recombinant nsp9 variants were expressed under iden-
tical culture conditions and batch puriﬁed using metal ion chro-
matography, with Co2þ targeting the C-terminal hexahistidine tag
of both polypeptides. As Fig. 1A shows, both proteins could be
obtained with similar purity, but nsp9/pASK was expressed in
higher quantities than nsp9/pDEST. Attempts to further purify the
proteins by gel ﬁltration did not result in a signiﬁcant improve-
ment, as judged by silver staining of SDS-PAGE gels (data not
shown).
T7 RNA polymerase contamination may account for de novo activity
observed with EAV nsp9/pDEST preparations
The preparations of nsp9/pDEST and nsp9/pASK were tested
side-by-side in a de novo polymerase assay as described before
(Beerens et al., 2007). The only noteworthy difference was the
length of the pU template, which was 30 nucleotides in our
experiments compared to an undeﬁned mixture containing RNAs
of up to 300 nucleotides in the study of Beerens et al. Unfortu-
nately, neither of the nsp9 variants showed any activity on this
template. Next, we tested for RdRp activity using a template
whose 30-terminal dinucleotide matched the CC dinucleotide that
is present immediately upstream of the poly(A) tail at the 30 end of
the EAV genome. Indeed, as previously shown for homopolymeric
pC templates, nsp9/pDEST exhibited some activity with this RNA
template, while nsp9/pASK remained essentially inactive (Fig. 1B,
middle and left panel, respectively, lanes R1).
The nsp9/pDEST protein differed from nsp9/pASK in having an
artiﬁcial N-terminal residue and in being produced by induction of
T7 RNA polymerase expression. We reasoned that the latter fea-
ture, expression of an additional polymerase, may be linked to the
(gain of) activity observed for the nsp9/pDEST preparation. To test
this hypothesis, we included a highly diluted sample (0.01 U/ml
ﬁnal concentration) of a commercially available T7 RNA poly-
merase in our assays. Since this enzyme is DNA-dependent, we
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of the RNA template used and a DNA template containing the
complement of the T7 promoter sequence (D4). Surprisingly, T7
RNA polymerase was active on all of these templates under the
employed conditions (Fig. 1B, right panel) with the expected
preference for DNA templates.
Strikingly, the nsp9/pDEST preparation showed the same
overall pattern, including the preference for DNA templates, as the
commercial T7 RNA polymerase. In line with this notion, an nsp9/
pASK preparation gained de novo activity once it was expressed in
BL21 (DE3) after addition of IPTG (data not shown). Hence, this
circumstantial evidence suggested that contaminating T7 RNA
polymerase, rather than EAV nsp9 itself, was responsible for the de
novo polymerase activity observed. We investigated whether a gel
ﬁltration step with a low ﬂow rate (0.3 ml/min) would remove the
suspected trace contamination of T7 RNA polymerase (molecular
weight 99 kDa) from a preparation of nsp9/pDEST (molecular
weight 78 kDa), but this was not found to be the case (data not
shown).
In conclusion, our results revealed that the polymerase assay
employing 32P-labeled NTPs, which was used in this and previous
studies, is sensitive enough to detect the activity of trace amounts
of contaminating T7 RNA polymerase. This polymerase was also
able to act on templates lacking the established T7 promoter
requirements. Whether or not this contamination was also present
in the nsp9 preparations described in Beerens et al. (2007), and
later on also by te Velthuis et al. (2010b), cannot be established
with certainty as the experiments presented here and those
published previously differed in some respects. Particularly the
previously used puriﬁcation protocol could not be reproduced in
our experiments due to technical difﬁculties with the described
puriﬁcation buffer, which in our hands induced protein pre-
cipitation during puriﬁcation. Also, the fact that we did not detect
any RdRp activity for nsp9/pDEST on a pU template, and therefore
also not for any potential contaminant, may argue in favor of the
detection of genuine nsp9 activity in those previous studies. In this
context, it is noteworthy that thus far the two reported cor-
onavirus RdRp activities (associated with nsp8 and nsp12) were
addressed in six independent biochemical studies (Ahn et al.,
2012; Imbert et al., 2006; Subissi et al., 2014; te Velthuis et al.,
2010a, 2012; Xiao et al., 2012), none of which succeeded in exactly
reproducing the results of any of the others. This may indicate that
nidovirus RdRps are highly delicate proteins that may respond to
minute changes during puriﬁcation or in their reaction
environment.
EAV nsp9/pASK preparations possess primer-dependent polymerase
and terminal transferase activity on RNA substrates
Besides testing for de novo activity, we analyzed whether EAV
nsp9 may possess primer-dependent polymerase activity, like its
coronavirus homolog nsp12 (Subissi et al., 2014; te Velthuis et al.,
2010a). We used a similar assay as the one described above, but
this time provided partially double-stranded templates. We found
that both nsp9 preparations were enzymatically active on these
templates and showed the highest extension activity if both the
template and primer were RNAs (Fig. 1C, left and middle panel).
The impact of the type of substrate showed that the observed
activity correlated directly with the addition of nucleic acid sub-
strates, hence was not based on a co-puriﬁed E. coli-derived RNA
or DNA substrate. Furthermore, as the presence of a DNA template
signiﬁcantly decreased processivity, it also demonstrated that the
responsible polymerase was RNA dependent. Interestingly, while
the use of a DNA primer in combination with an RNA template
completely precluded extension of the primer (no products in the
20–39 nucleotide size range), a radiolabeled 40-nucleotideproduct was detected. This suggested that the polymerase pos-
sessed terminal transferase activity, but only on RNA substrates. To
investigate this further, we also compared the elongation of single-
stranded RNA and DNA substrates in an assay otherwise identical
to the one used for measuring primer-dependent polymerase
activity (Fig. 1D). As expected, both nsp9 preparations showed a
clear selectivity in favor of RNA. In this context, it is also note-
worthy that neither the primer extension nor the terminal trans-
ferase assay buffer included Mn2þ ions, which can favor activity
on sub-optimal templates (Arnold et al., 1999). Together with the
demonstrated DNA speciﬁcity of T7 RNA polymerase (Fig. 1C and
D, right panels) this supports the reliability of these assays with
respect to reproducing physiologically relevant substrate
preferences.
To conclude the characterization of the polymerase, its
nucleotide preference was examined. To this end, a primed RNA
template (Fig. 2A) was ﬁrst elongated in the presence of a low
concentration of radiolabeled ATP, resulting in frequent abortion of
transcription after incorporation of the ﬁrst nucleotide. Subse-
quently, either dATP or ATP was supplied in a concentration that
should allow restarting and completion of the reaction (Fig. 2B). As
expected, addition of ATP enabled the synthesis of almost fully
extended products, while dATP did not support any extension
beyond one or two nucleotides (Fig. 2C). In agreement with the
lack of DNA primer extension and the known inability of the
prototypic poliovirus RdRp to further extend deoxynucleotide
chains (Arnold and Cameron, 2004; Gohara et al., 2000), we thus
conclude that the observed activity originated from an RNA-
dependent RNA polymerase.
EAV mutants carrying replacements of active-site aspartates of the
nsp9 RdRp
Polymerase activity is primarily based on a two-metal-ion
mechanism involving several residues. In contrast to other cata-
lytic mechanisms, which may feature a single or a few absolutely
required residues, these individual amino acids work in concert
during metal catalysis to provide a framework for metal ions and
substrates to bind. Consequently, instead of abolishing all activity,
the substitution of single residues in the active site of an RdRp may
merely reduce these binding afﬁnities. Thus, depending on the
individual contribution of a residue, such replacements may be
more or less detrimental to the enzyme's function, and conse-
quently to virus viability.
To establish whether the observed activity was associated with
the RdRp domain of EAV nsp9, we substituted several key residues
of its (predicted) active site (Beerens et al., 2007; Den Boon et al.,
1991) with alanine. Using a full-length cDNA clone, we engineered
EAV nsp9 mutants with alanine substitutions of each of the four
conserved aspartates of motifs A (mutants D445A, D450A and
double mutant D445A/D450A) and C (mutant D560A and double
mutant D559A/D560A), which in better characterized polymerases
are known to coordinate the essential metal ions or interact with
the NTP's 20 and 30 hydroxyl groups. In agreement with their
expected essential role, and with our preliminary observations for
equivalent SARS-CoV nsp12 mutants (unpublished data), each of
the aspartate-to-alanine substitutions tested had a severe impact
on viral replication. Whereas all double mutations tested were
lethal, viruses carrying single mutations apparently retained a low
level of RNA synthesis, ultimately leading to reversion to the wild-
type genome sequence later in the experiment (by 48 h p.t.; see
also Supplementary Table S2). In all cases, a single point mutation
was sufﬁcient to restore the codon for the wild-type residue.
Nevertheless, the results were somewhat unexpected given the
universal conservation of all four aspartates in positive-stranded
RNA virus RdRps. To our knowledge replication of mutants with a
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severely decreased and undetectable until reversion had occurred,
has not been reported for any other RNA virus thus far.
Observed primer extension and terminal transferase activities cannot
be attributed to EAV nsp9 RdRp
Following the reverse genetics studies on the RdRp active site
of nsp9, we transferred the same mutations to the nsp9/pASK
expression construct to obtain negative controls for theFig. 1. Expression, puriﬁcation, and RNA polymerase activities of two recombinant E
respectively. Identical numbers indicate templates with equivalent sequences. Template s
the right or left side of the ﬁgures. (A) Coomassie brilliant blue-stained SDS-PAGE gel of
respective fractions after cell lysis; after binding: unbound protein after removal of Co2þ
78 kDa. Size markers are depicted on the right in kDa. (B) de novo polymerase assay using
(nsp9/pDEST; ﬁnal protein concentration 0.6 mM) vectors, or using commercial T7 RNA p
ATP, 0.7 mM GTP, 0.7 mM UTP and 0.17 mM [α-32P]CTP. Products longer than template len
template or the newly synthesized strand. D4 template length 45 nt (C) Results of a prime
concentration 1 mM), nsp9/pDEST (ﬁnal protein concentration 0.3 mM), or commercial T7
[α-32P]ATP. Products longer than template length (29 nt for R2, 39 nt for R3 and D3) must
newly synthesized strand. (D) Results of a terminal transferase assay. The signal at the v
the high-percentage acrylamide gel used here. Note that products resulting from end-labiochemical RdRp assays described in the previous paragraphs.
None of the double, triple, or quadruple aspartate-to-alanine
substitutions tested showed a decreased primer extension activ-
ity compared to two independently puriﬁed batches of wild-type
recombinant nsp9/pASK (Fig. 3). Likewise, D445A and D560A
mutant proteins retained terminal transferase activity (data not
shown). Thus, the observed activities either derived from a second
active site within nsp9, which was not targeted by mutagenesis, or
originated from a different (contaminating) protein altogether. To
discriminate between these possibilities, we tested whether it wasAV nsp9-His preparations. R and D indicate the use of RNA and DNA templates,
equences are listed in Supplementary Table S1. Product lengths (nt) are indicated on
samples taken during metal ion chromatography using Co2þ . Insoluble and soluble:
resin; eluate: elution fraction after puriﬁcation. The molecular weight of nsp9-His is
nsp9 expressed from pASK (nsp9/pASK; ﬁnal protein concentration 2 mM) or pDest
olymerase (0.05 U per sample). Assays were performed in the presence of 1.5 mM
gth, 30 nt for R1 and D1, result from terminal transferase activity acting on either the
r extension assay (primer length 19 nt) using recombinant nsp9/pASK (ﬁnal protein
RNA polymerase (0.025 U per sample), in the presence of 50 mM ATP and 0.17 mM
have resulted from terminal transferase activity acting on either the template or the
ery top of the gel likely represents products of 4200 nt that cannot be resolved in
beling with ATP may be further extended by a back-priming mechanism.
Fig. 2. Stop-and-go primer extension assay using EAV nsp9-His expressed from a pASK vector and primer/template R/R3 in the presence of ATP or dATP. (A) Sequence of
primer/template. (B) Schematic representation of the experimental design. (C) Polymerase products after interrupted and resumed synthesis. The sizes of primer extension
products are indicated on the right.
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active ones during puriﬁcation of the quadruple nsp9/pASK
aspartate-to-alanine mutant. To this end, the wash steps of the
previously established puriﬁcation protocol were modiﬁed in
either of two ways; ﬁrst, a decreasing salt gradient was introduced
to weaken (disrupt) hydrophobic interactions between a con-
taminant and nsp9, and second, an increasing imidazole con-
centration was employed in order to eliminate any contaminant
from the Co2þ-resin. As shown in Fig. 4, the NaCl elution fraction
and wash steps 2 and 3 of the imidazole gradient contained almost
identical amounts of nsp9-His, as judged by SDS-PAGE, while two
of these three fractions were inactive in the polymerase assay. This
partial correlation between the presence of recombinant nsp9-His
and primer extension activity could be due to either the presence
of two forms of nsp9, enzymatically active and defective, or the
presence of a second enzyme responsible for the activity. Although
the nature and origin of the possible heterogeneity of nsp9
remains elusive, a candidate protein from E. coli that may account
at least for the contaminating terminal transferase activity is polyA
polymerase I (PAP I), which has been reported to add a polyA tail
to RNA substrates in a template-independent manner in vitro
(Yehudai-Resheff and Schuster, 2000). Whether or not this enzyme
or other E. coli terminal transferases would also be capable to
extend primers in a template-dependent manner is, to our
knowledge, currently unknown, but seems unlikely given PAP I's
physiological role.Conclusion
In this study we could neither conﬁrm the previously reported de
novo polymerase activity nor detect any other RNA polymerase
activity speciﬁcally originating from puriﬁed recombinant EAV nsp9-
His, indicating that the in vitro characterization of the arterivirus
RdRp presents a formidable challenge. One possibility is that the
activity depends on the presence of one or more (viral) protein co-
factor(s) or speciﬁc RNA sequences that we have not been able to
identify thus far, despite attempts to supplement RdRp assays with
several small products from the nsp6-8 region (not shown). While
the reasons underlying the differences with earlier studies on nsp9
remain to be elucidated, the outcome of the present study empha-
sizes the need for designing proper controls, especially when utiliz-
ing highly sensitive biochemical assays for the characterization of
enzymes with low activity. Furthermore, it illustrates that in vitro
assays may reveal activities that are not biologically relevant underphysiological conditions or in the presence of interaction partners
that may alter substrate preferences by modifying an enzyme's
conformation. Being aware of these pitfalls probably is one of the
most fundamental prerequisites for the deduction of biological roles
from biochemical assays.Material and methods
Protein expression and puriﬁcation
C-terminally His-tagged fusion proteins of wild-type and
mutant EAV nsp9 were expressed under the control of a tetra-
cycline promoter from a pASK vector in the E. coli BL21 derivative
C2523/pCG1 as described (Gohara et al., 1999; te Velthuis et al.,
2012). As a reference, nsp9-His6 was expressed from a previously
used pDEST construct in E. coli BL21 (DE3) cells after IPTG induc-
tion under otherwise identical conditions. Proteins were puriﬁed
by metal afﬁnity chromatography using Co2þ (Talon beads) as
described (te Velthuis et al., 2012) using a buffer containing
20 mM HEPES, pH 7.5, 500 mM NaCl, 10% glycerol (v/v), 10 mM
imidazole, and 5 mM β-mercaptoethanol unless stated otherwise.
Where indicated, a second puriﬁcation step using a Superdex 200
10/300 GL gel ﬁltration column and a buffer containing 20 mM
HEPES, pH 7.5, 300 mM NaCl, and 1 mM DTT was performed at
4 °C using a ﬂow rate of 0.3 ml/min.
RNA polymerase assays
Three different types of RNA polymerase assays were performed:
de novo initiation, primer extension, and terminal transferase
assays. For de novo assays samples contained 10 mM Tris, pH 8.0,
5 mM KCl, 25 mM NaCl (including 20 mM from the protein storage
buffer), 6 mM MgCl2, 1.5 mM MnCl2, 1.5 mM DTT, 12.5% glycerol
(including 10% from the protein storage buffer), 0.005% Triton
X-100, 1.5 U RiboLock RNase inhibitor (Thermo Scientiﬁc), 0.5 mM
single-stranded nucleic acid template, 1.5 mM ATP, if required
0.7 mM GTP and 0.7 mM UTP, 0.17 mM [α-32P]CTP (Perkin Elmer,
3000 Ci/mmol), and 2 mM nsp9/pASK or 0.6 mM nsp9/pDEST or
0.05 U T7 RNA polymerase from a commercial source (Life Tech-
nologies). Primer extension and terminal transferase assays were
performed in 20 mM Tris, pH 8.0, 10 mM KCl, 20 mM NaCl
(including 10 mM from the protein storage buffer), 6 mM MgCl2,
1 mM DTT, 10% glycerol (including 5% from the protein storage
buffer), 0.01% Triton X-100, 0.5 U RiboLock RNase inhibitor, 1 mM
Fig. 3. Primer extension assay on primer/template R/R3 using wild-type EAV nsp9-
His expressed from a pASK vector and mutants in which essential aspartate resi-
dues of the RdRp domain were replaced with alanine (D445 and D450 of motif A,
D559 and D560 of motif C). The sizes of primer extension products are indicated on
the right; reactions were performed in the presence of 50 mM ATP and 0.17 mM
[α-32P]ATP.
Fig. 4. Correlation between EAV nsp9-containing fractions and primer extension
activity. (A) Coomassie brilliant blue-stained SDS-PAGE gel of samples taken during
the puriﬁcation of nsp9/pASK by Co2þ afﬁnity chromatography using wash buffers
with either a decreasing NaCl concentration or an increasing imidazole con-
centration. Size markers are depicted on the left in kDa. (B) The samples shown in A
were examined for primer extension activity on primer/template R/R3. The sizes of
primer extension products are indicated on the right.
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(terminal transferase) nucleic acid, 50 mM ATP, 0.17 mM [α-32P]ATP
(Perkin Elmer, 3000 Ci/mmol), and 1 mM nsp9/pASK or 0.3 mMnsp9/
pDEST or 0.025 U T7 RNA polymerase (Life Technologies). Sequen-
ces of used nucleic acids are listed in Supplementary Table S1.
Nucleic acids were annealed with complementary primers by
heating to 95 °C for 2 min, then keeping them at 52 °C for 30 min,
and ﬁnally letting them cool to room temperature in 30 min.
In all three assays, samples were incubated for 1 h at 30 °C
before the reaction was stopped by addition of an equal volume of
formamide-based gel loading buffer (95% formamide, 18 mM
EDTA, 0.025% SDS, xylene cyanol, bromophenol blue) and 2 min
denaturation at 95 °C. Products were separated by gel electro-
phoresis in 20% polyacrylamide gels (19:1) containing 7 M urea.
Gels were run in 0.5x Tris–borate–EDTA (TBE) buffer and phos-
phorimaging was performed using a Typhoon variable mode
scanner (GE Healthcare). Band intensities were analyzed with
ImageQuant TL software (GE Healthcare).
EAV reverse genetics
Codons specifying conserved nsp9 residues were replaced with
alanine codons using the QuikChange protocol and were introduced
into full-length cDNA clone pEAV211 (van den Born et al., 2005; vanDinten et al., 1997) using appropriate shuttle vectors and restriction
enzymes. Synthesis of full-length RNA and transfection of BHK-21
cells was performed as described previously (Nedialkova et al.,
2010). Transfected cells were monitored until 72 h post transfection
(p.t.) by immunoﬂuorescence microscopy using antibodies directed
against the nsp3 and N proteins as described (van der Meer et al.,
1998). To monitor the production of viral progeny, supernatants
were harvested at 48 h p.t. and plaque assays were performed as
described (Nedialkova et al., 2010). To verify the presence of the
introduced mutations or reversions in viable mutants, fresh BHK-21
cells were infected with supernatants harvested at 72 h p.t., RNA
was isolated with TriPure after 18 h, and the nsp9-coding region
was ampliﬁed by RT-PCR and sequenced.Acknowledgments
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